Serina Therapeutics, Inc. Line of Credit, Current
Serina Therapeutics, Inc. (SER) had Line of Credit, Current of $2.00 billion as of 2023-12-31, per its 10-K filed 2024-03-22.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LinesOfCreditCurrent · last filed 2024-03-22
- 2023-12-31: Line of Credit, Current $2.00B.
- 2023-09-30: Line of Credit, Current $2.00B.
- 2023-06-30: Line of Credit, Current $2.00B.
- 2023-03-31: Line of Credit, Current $2.00B.
| Period end | Line of Credit, Current |
|---|---|
| 2023-12-31 | $2.00B 10-K · filed 2024-03-22 |
| 2023-09-30 | $2.00B 10-Q · filed 2023-11-14 |
| 2023-06-30 | $2.00B 10-Q · filed 2023-08-14 |
| 2023-03-31 | $2.00B 10-Q · filed 2023-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |